168
J. Pospíšil et al.
235. Ishii T, Mori T, Tanaka T, Mizuno D, Yamaji R, Kumazawa S, Nakayama T, Akagawa M
(2008) Covalent modification of proteins by green tea polyphenol (–)-epigallocatechin-3gallate through autoxidation. Free Radic Biol Med 45:1384
236. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein
IB (2007) The inhibitory effect of (–)-epigallocatechin gallate on activation of the epidermal
growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer
Res 67:6493
237. Duhon D, Bigelow RLH, Coleman DT, Steffan JJ, Yu C, Langston W, Kevil CG, Cardelli JA
(2010) The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the
c-Met receptor in prostate cancer cells. Mol Carcinog 749:739
238. Fujimura Y, Yamada K, Tachibana H (2005) A lipid raft-associated 67kDa laminin receptor
mediates suppressive effect of epigallocatechin-3-O-gallate on FcεRI expression. Biochem
Biophys Res Commun 336:674
239. Tipoe GL, Leung TM, Liong EC, Lau TYH, Fung ML, Nanji AA (2010) Epigallocatechin3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon
tetrachloride (CCl 4 )-induced liver injury in mice. Toxicology 273:45
240. Shankar E, Kanwal R, Candamo M, Gupta S (2016) Dietary phytochemicals as epigenetic
modifiers in cancer: promise and challenges. Semin Cancer Biol 40–41:82
241. Chosa H, Toda M, Okubo S, Hara Y, Shimamura T (1992) Antimicrobial and microbicidal
activities of tea and catechins against mycoplasma. Kansenshogaku Zasshi 66:606
242. Blanco AR, La Terra Mulè S, Babini G, Garbisa S, Enea V, Rusciano D (2003) (–)Epigallocatechin-3-gallate inhibits gelatinase activity of some bacterial isolates from ocular
infection, and limits their invasion through gelatine. Biochim Biophys Acta 1620:273
243. Hirasawa M, Takada K, Otake S (2006) Inhibition of acid production in dental plaque bacteria
by green tea catechins. Caries Res 40:265
244. Sawamura S, Sakane I, Satoh E, Ishii T, Shimizu Y, Nishimura M, Umehara K (2002) Isolation
and determination of an antidote for botulinum neurotoxin from black tea extract. Nihon
Yakurigaku Zasshi 120:116P
245. Dell’Aica I, Donà M, Tonello F, Piris A, Mock M, Montecucco M, Garbisa S (2004) Potent
inhibitors of anthrax lethal factor from green tea. EMBO Rep 5:418
246. Friedman M, Henika PR, Levin CE, Mandrell RE (2006) Antimicrobial activities of tea
catechins and theaflavins and tea extracts against Bacillus cereus. J Food Prot 69:354
247. Hamilton-Miller JM (1995) Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob
Agents Chemother 39:2375
248. Lee HC, Jenner AM, Low CS, Lee YK (2006) Effect of tea phenolics and their aromatic fecal
bacterial metabolites on intestinal microbiota. Res Microbiol 157:876
249. Satoh E, Ishii T, Shimizu Y, Sawamura S, Nishimura M (2002) A mechanism of the thearubigin
fraction of black tea (Camellia sinensis) extract protecting against the effect of tetanus toxin.
J Toxicol Sci 27:441
250. Chou CC, Lin LL, Chung KT (1999) Antimicrobial activity of tea as affected by the degree
of fermentation and manufacturing season. Int J Food Microbiol 48:125
251. Isogai E, Isogai H, Takeshi K, Nishikawa T (1998) Protective effect of Japanese green tea
extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Microbiol
Immunol 42:125
252. Taguri T, Tanaka T, Kouno I (2004) Antimicrobial activity of 10 different plant polyphenols
against bacteria causing food-borne disease. Biol Pharm Bull 27:1965
253. Yanagawa Y, Yamamoto Y, Hara Y, Shimamura T (2003) A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter
pylori growth in vitro. Curr Microbiol 47:244
254. Yee Y-K, Koo MW, Szeto M-L (2002) Chinese tea consumption and lower risk of Helicobacter
infection. J Gastroenterol Hepatol 17:552
255. Lee K-M, Yeo M, Choue J-S, Jin JH, Park SJ, Cheong JY, Lee KJ, Kim JH, Hahm
KB (2004) Protective mechanism of epigallocatechin-3-gallate against Helicobacter pyloriinduced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter
9:632
J. Pospíšil et al.
235. Ishii T, Mori T, Tanaka T, Mizuno D, Yamaji R, Kumazawa S, Nakayama T, Akagawa M
(2008) Covalent modification of proteins by green tea polyphenol (–)-epigallocatechin-3gallate through autoxidation. Free Radic Biol Med 45:1384
236. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, Weinstein
IB (2007) The inhibitory effect of (–)-epigallocatechin gallate on activation of the epidermal
growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer
Res 67:6493
237. Duhon D, Bigelow RLH, Coleman DT, Steffan JJ, Yu C, Langston W, Kevil CG, Cardelli JA
(2010) The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the
c-Met receptor in prostate cancer cells. Mol Carcinog 749:739
238. Fujimura Y, Yamada K, Tachibana H (2005) A lipid raft-associated 67kDa laminin receptor
mediates suppressive effect of epigallocatechin-3-O-gallate on FcεRI expression. Biochem
Biophys Res Commun 336:674
239. Tipoe GL, Leung TM, Liong EC, Lau TYH, Fung ML, Nanji AA (2010) Epigallocatechin3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon
tetrachloride (CCl 4 )-induced liver injury in mice. Toxicology 273:45
240. Shankar E, Kanwal R, Candamo M, Gupta S (2016) Dietary phytochemicals as epigenetic
modifiers in cancer: promise and challenges. Semin Cancer Biol 40–41:82
241. Chosa H, Toda M, Okubo S, Hara Y, Shimamura T (1992) Antimicrobial and microbicidal
activities of tea and catechins against mycoplasma. Kansenshogaku Zasshi 66:606
242. Blanco AR, La Terra Mulè S, Babini G, Garbisa S, Enea V, Rusciano D (2003) (–)Epigallocatechin-3-gallate inhibits gelatinase activity of some bacterial isolates from ocular
infection, and limits their invasion through gelatine. Biochim Biophys Acta 1620:273
243. Hirasawa M, Takada K, Otake S (2006) Inhibition of acid production in dental plaque bacteria
by green tea catechins. Caries Res 40:265
244. Sawamura S, Sakane I, Satoh E, Ishii T, Shimizu Y, Nishimura M, Umehara K (2002) Isolation
and determination of an antidote for botulinum neurotoxin from black tea extract. Nihon
Yakurigaku Zasshi 120:116P
245. Dell’Aica I, Donà M, Tonello F, Piris A, Mock M, Montecucco M, Garbisa S (2004) Potent
inhibitors of anthrax lethal factor from green tea. EMBO Rep 5:418
246. Friedman M, Henika PR, Levin CE, Mandrell RE (2006) Antimicrobial activities of tea
catechins and theaflavins and tea extracts against Bacillus cereus. J Food Prot 69:354
247. Hamilton-Miller JM (1995) Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob
Agents Chemother 39:2375
248. Lee HC, Jenner AM, Low CS, Lee YK (2006) Effect of tea phenolics and their aromatic fecal
bacterial metabolites on intestinal microbiota. Res Microbiol 157:876
249. Satoh E, Ishii T, Shimizu Y, Sawamura S, Nishimura M (2002) A mechanism of the thearubigin
fraction of black tea (Camellia sinensis) extract protecting against the effect of tetanus toxin.
J Toxicol Sci 27:441
250. Chou CC, Lin LL, Chung KT (1999) Antimicrobial activity of tea as affected by the degree
of fermentation and manufacturing season. Int J Food Microbiol 48:125
251. Isogai E, Isogai H, Takeshi K, Nishikawa T (1998) Protective effect of Japanese green tea
extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Microbiol
Immunol 42:125
252. Taguri T, Tanaka T, Kouno I (2004) Antimicrobial activity of 10 different plant polyphenols
against bacteria causing food-borne disease. Biol Pharm Bull 27:1965
253. Yanagawa Y, Yamamoto Y, Hara Y, Shimamura T (2003) A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter
pylori growth in vitro. Curr Microbiol 47:244
254. Yee Y-K, Koo MW, Szeto M-L (2002) Chinese tea consumption and lower risk of Helicobacter
infection. J Gastroenterol Hepatol 17:552
255. Lee K-M, Yeo M, Choue J-S, Jin JH, Park SJ, Cheong JY, Lee KJ, Kim JH, Hahm
KB (2004) Protective mechanism of epigallocatechin-3-gallate against Helicobacter pyloriinduced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter
9:632